SERPINE2/PN-1 regulates the DNA damage response and radioresistance by activating ATM in lung cancer
- PMID: 34648881
- DOI: 10.1016/j.canlet.2021.10.001
SERPINE2/PN-1 regulates the DNA damage response and radioresistance by activating ATM in lung cancer
Erratum in
-
Corrigendum to "SERPINE2/PN-1 regulates the DNA damage response and radioresistance by activating ATM in lung cancer" [Cancer Lett. 524 (2022) 268-283].Cancer Lett. 2025 Feb 1;610:217337. doi: 10.1016/j.canlet.2024.217337. Epub 2024 Nov 24. Cancer Lett. 2025. PMID: 39581824 No abstract available.
Abstract
Although the DNA damage response (DDR) is associated with the radioresistance characteristics of lung cancer cells, the specific regulators and underlying mechanisms of the DDR are unclear. Here, we identified the serine proteinase inhibitor clade E member 2 (SERPINE2) as a modulator of radiosensitivity and the DDR in lung cancer. Cells exhibiting radioresistance after ionizing radiation show upregulation of SERPINE2, and SERPINE2 knockdown improves tumor radiosensitivity in vitro and in vivo. Functionally, SERPINE2 deficiency causes a reduction in homologous recombination repair, rapid recovery of cell cycle checkpoints, and suppression of migration and invasion. Mechanistically, SERPINE2 knockdown inhibits the accumulation of p-ATM and the downstream repair protein RAD51 during DNA repair, and RAD51 can restore DNA damage and radioresistance phenotypes in lung cancer cells. Furthermore, SERPINE2 can directly interact with MRE11 and ATM to facilitate its phosphorylation in HR-mediated DSB repair. In addition, high SERPINE2 expression correlates with dismal prognosis in lung adenocarcinoma patients, and a high serum SERPINE2 concentration predicts a poor response to radiotherapy in non-small cell lung cancer patients. In summary, these findings indicate a novel regulatory mechanism by which SERPINE2 modulates the DDR and radioresistance in lung cancer.
Keywords: ATM; DNA damage response; Homologous recombination; SERPINE2; radioresistance.
Copyright © 2021 The Authors. Published by Elsevier B.V. All rights reserved.
Similar articles
-
S6K1 Controls DNA Damage Signaling Modulated by the MRN Complex to Induce Radioresistance in Lung Cancer.Int J Mol Sci. 2024 Sep 28;25(19):10461. doi: 10.3390/ijms251910461. Int J Mol Sci. 2024. PMID: 39408794 Free PMC article.
-
ATM Expression Is Elevated in Established Radiation-Resistant Breast Cancer Cells and Improves DNA Repair Efficiency.Int J Biol Sci. 2020 Feb 4;16(7):1096-1106. doi: 10.7150/ijbs.41246. eCollection 2020. Int J Biol Sci. 2020. PMID: 32174787 Free PMC article.
-
The ATM inhibitor KU55933 sensitizes radioresistant bladder cancer cells with DAB2IP gene defect.Int J Radiat Biol. 2015 Apr;91(4):368-78. doi: 10.3109/09553002.2015.1001531. Epub 2015 Feb 6. Int J Radiat Biol. 2015. PMID: 25585815
-
The controlling role of ATM in homologous recombinational repair of DNA damage.EMBO J. 2000 Feb 1;19(3):463-71. doi: 10.1093/emboj/19.3.463. EMBO J. 2000. PMID: 10654944 Free PMC article.
-
Genetic variations in DNA repair genes, radiosensitivity to cancer and susceptibility to acute tissue reactions in radiotherapy-treated cancer patients.Acta Oncol. 2008;47(5):809-24. doi: 10.1080/02841860801885969. Acta Oncol. 2008. PMID: 18568480 Review.
Cited by
-
A novel signature constructed by differential genes of muscle-invasive and non-muscle-invasive bladder cancer for the prediction of prognosis in bladder cancer.Front Immunol. 2023 Aug 24;14:1187286. doi: 10.3389/fimmu.2023.1187286. eCollection 2023. Front Immunol. 2023. PMID: 37691944 Free PMC article.
-
Development of cancer-associated fibroblast-related gene signature for predicting the survival and immunotherapy response in lung adenocarcinoma.Aging (Albany NY). 2023 Jun 6;15(11):4986-5006. doi: 10.18632/aging.204774. Epub 2023 Jun 6. Aging (Albany NY). 2023. PMID: 37280069 Free PMC article.
-
Pan-cancer analysis of SERPINE family genes as biomarkers of cancer prognosis and response to therapy.Front Mol Biosci. 2024 Jan 11;10:1277508. doi: 10.3389/fmolb.2023.1277508. eCollection 2023. Front Mol Biosci. 2024. PMID: 38274096 Free PMC article.
-
Targeting FBXO22 enhances radiosensitivity in non-small cell lung cancer by inhibiting the FOXM1/Rad51 axis.Cell Death Dis. 2024 Jan 31;15(1):104. doi: 10.1038/s41419-024-06484-1. Cell Death Dis. 2024. PMID: 38296976 Free PMC article.
-
Review: Mechanisms and perspective treatment of radioresistance in non-small cell lung cancer.Front Immunol. 2023 Feb 14;14:1133899. doi: 10.3389/fimmu.2023.1133899. eCollection 2023. Front Immunol. 2023. PMID: 36865554 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous